Charles River Laboratories International, Inc.

Charles River Laboratories International is a leading global Contract Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, and medical device companies throughout the drug discovery and development process. Established in 1947 and headquartered in Wilmington, Massachusetts, USA, the company operates in more than 20 countries and provides comprehensive preclinical and early-stage clinical research services to thousands of life sciences organizations worldwide.

Charles River specializes in discovery research, laboratory testing, safety assessment, toxicology, pharmacology, bioanalytical services, biologics testing, microbial solutions, cell and gene therapy support, and regulatory consulting. The company helps clients identify promising drug candidates, evaluate safety and efficacy, and prepare products for clinical trials and regulatory approval.

Its extensive global network of research facilities, laboratories, and scientific experts enables Charles River to deliver integrated solutions that accelerate drug development while maintaining the highest standards of quality, ethics, and regulatory compliance. The organization continuously invests in artificial intelligence, digital pathology, automation, advanced laboratory technologies, and alternative testing methods to improve research efficiency and scientific outcomes.

With more than seven decades of scientific experience, Charles River Laboratories remains one of the world’s most trusted partners for preclinical research, laboratory sciences, and pharmaceutical development, helping bring innovative therapies to patients faster.